Pieter Claes

Company: Confo Therapeutics

Job title: principal scientist

Seminars:

A Curious Journey in OX2R Drug Discovery 3:30 pm

Identification of an agonist series using a new screening assay based on ConfoBodies® Elaboration of the chemical series gave a puzzling structure activity relationship Determination of the active state structure with a series representative revealed the cause of these unexpected activity cliffsRead more

day: Conference Day One